Besides its oncogenic activity in AML cells, AXL was found to contribute to AML progression and relapse by supporting the maintenance and survival of LSCs through the lysine demethylase 4 C (KDM4C)-ALKBH5-AXL signaling axis [101]. This evidence concerns the gene KDM4C and acute myeloid leukemia.